San Francisco, CA, United States of America

Nathan H Harding

This inventor holds 30 USPTO granted patents, plus 9 CIPO patents and 20 EPO patents, primarily in Cosmetic Robotics. Top assignees: Ekso Bionics, Inc., University of California, Wink Robotics. Active years: 2000-2023.


% Patents Active = 90.0


 

Average Co-Inventor Count = 3.7

ph-index = 13

Forward Citations = 616(Granted Patents)


Location History:

  • San Francisco, CA (US) (2000 - 2006)
  • Oakland, CA (US) (2008 - 2023)

Company Filing History:


Years Active: 2000-2023

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Detachable End Effectors
Cosmetic Robotics
Eyelash Extension
Exoskeleton Technology
Operator Engagement
Wearable Material Handling
Lower Extremity Orthotic
Human Machine Interface
Energy Consumption Reduction
Prosthetic Knee
Multi-Axis Motion Controller
Self Teaching Robotics
30 patents (USPTO):Explore Patents

Title: Nathan H. Harding: Pioneering Inventor from San Francisco

Introduction: Nathan H. Harding is a renowned inventor based in San Francisco, CA, known for his groundbreaking contributions to various industries.

Latest Patents: Nathan H. Harding holds several patents in the fields of technology, healthcare, and sustainability, showcasing his diverse range of innovative ideas.

Career Highlights: With a career spanning over two decades, Nathan H. Harding has established himself as a visionary inventor, with a keen focus on developing solutions that address real-world challenges.

Collaborations: Throughout his career, Nathan H. Harding has collaborated with leading companies, research institutions, and universities to bring his inventions to life, fostering a culture of innovation and creativity.

Conclusion: Nathan H. Harding's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors, making him a true pioneer in the world of technology and beyond.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…